CSIMarket Company Name, Ticker, Customers, else..



Worst Performing Stocks In Total Market During This Current Quarter Q4 Of 2024


 1 Day   Week  Current Month of December  30 Days 
Current Quarter Q4 of 2024  90 Days    Ytd    12 Months 
 

Shares improved by 25.32% on average, in Total Market during this current quarter q4 of 2024.

Here are the Worst performing stocks in Total Market.




THMO

$0.0005

$-0.1895 -99.74%
This Quarter Q4 of 2024


THMO

$0.0005

$-0.1895 -99.74%



Thermogenesis Holdings Inc

Thermogenesis Holdings Inc stock went down -99.74% during this current quarter q4 of 2024.


Thermogenesis Holdings Inc is a company that operates in the medical technology industry. Their business model involves developing and manufacturing innovative products for the fields of regenerative medicine and cell therapy. They aim to provide solutions for efficient cell processing and storage, with a focus on improving patient outcomes and advancing medical research.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.002 mill. $ 8.561 mill. $ -15.738 mill. 4 mill. - Y/Y -14.39 %
Market Cap. Revenues TTM Net Income TTM

$ 0.002 mill.
$ 8.561 mill.


$ -15.738 mill.
Employees Shares Outstanding P/E

-
4 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -14.39 %
MRQ Y/Y - %


EFTR

$0.0002

$-0.0398 -99.50%
This Quarter Q4 of 2024


EFTR

$0.0002

$-0.0398 -99.50%



Effector Therapeutics Inc

Effector Therapeutics Inc stock declined -99.50% during this current quarter q4 of 2024.


Effector Therapeutics Inc is a biotech company focused on developing and commercializing effective cancer treatments.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.001 mill. $ - mill. $ -34.631 mill. 4 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.001 mill.
$ - mill.


$ -34.631 mill.
Employees Shares Outstanding P/E

-
4 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


GROM

$0.0004

$-0.0501 -99.21%
This Quarter Q4 of 2024


GROM

$0.0004

$-0.0501 -99.21%



Grom Social Enterprises Inc

Grom Social Enterprises Inc stock dropped -99.21% during this current quarter q4 of 2024.


Grom Social Enterprises Inc*s business model revolves around providing a safe and interactive online platform for children and teenagers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.001 mill. $ 3.716 mill. $ -15.712 mill. 3 mill. - Y/Y -27.13 %
Market Cap. Revenues TTM Net Income TTM

$ 0.001 mill.
$ 3.716 mill.


$ -15.712 mill.
Employees Shares Outstanding P/E

-
3 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -27.13 %
MRQ Y/Y - %


EBET

$0.001

$-0.0590 -98.33%
This Quarter Q4 of 2024


EBET

$0.001

$-0.0590 -98.33%



Ebet Inc

Ebet Inc shares declined -98.33% during this current quarter q4 of 2024.


Ebet Inc is a technology company that operates in the online gaming industry. Their business model revolves around developing and providing software solutions for online casinos and sportsbooks. They generate revenue by licensing their products to gambling operators and earning a percentage of the profits from their clients* transactions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.015 mill. $ 20.996 mill. $ -81.539 mill. 15 mill. - Y/Y -69.58 %
Market Cap. Revenues TTM Net Income TTM

$ 0.015 mill.
$ 20.996 mill.


$ -81.539 mill.
Employees Shares Outstanding P/E

-
15 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -69.58 %
MRQ Y/Y - %


CUEN

$0.004

$-0.1961 -98.00%
This Quarter Q4 of 2024


CUEN

$0.004

$-0.1961 -98.00%



Cuentas Inc

Cuentas Inc shares declined -98.00% during this current quarter q4 of 2024.


Cuentas Inc operates as a fintech company with a focus on providing digitally-based financial services. The company*s business model revolves around offering innovative solutions for unbanked and underbanked individuals through its various applications and platforms. By leveraging technology, Cuentas Inc aims to bridge the gap in financial inclusion and provide secure and convenient financial services to its target demographic.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.011 mill. $ 1.530 mill. $ -8.973 mill. 3 mill. - Y/Y -44.09 %
Market Cap. Revenues TTM Net Income TTM

$ 0.011 mill.
$ 1.530 mill.


$ -8.973 mill.
Employees Shares Outstanding P/E

-
3 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -44.09 %
MRQ Y/Y - %


RYDE

$0.3776

$-11.7624 -96.89%
This Quarter Q4 of 2024


RYDE

$0.3776

$-11.7624 -96.89%



Ryde Group Ltd

Ryde Group Ltd shares dropped -96.89% during this current quarter q4 of 2024.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.911 mill. $ 6.569 mill. $ -9.755 mill. 13 mill. - Y/Y 0.00 %
Market Cap. Revenues TTM Net Income TTM

$ 4.911 mill.
$ 6.569 mill.


$ -9.755 mill.
Employees Shares Outstanding P/E

-
13 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 0.00 %
MRQ Y/Y - %


ZPTA

$0.017

$-0.4420 -96.30%
This Quarter Q4 of 2024


ZPTA

$0.017

$-0.4420 -96.30%



Zapata Computing Holdings Inc

Zapata Computing Holdings Inc shares dropped -96.30% during this current quarter q4 of 2024.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.547 mill. $ 3.219 mill. $ -40.559 mill. 32 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.547 mill.
$ 3.219 mill.


$ -40.559 mill.
Employees Shares Outstanding P/E

-
32 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


AWIN

$0.004

$-0.0960 -96.00%
This Quarter Q4 of 2024


AWIN

$0.004

$-0.0960 -96.00%



Aerwins Technologies Inc

Aerwins Technologies Inc shares went down -96.00% during this current quarter q4 of 2024.


Aerwins Technologies Inc is a software development company that focuses on providing customized technological solutions for businesses.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.003 mill. $ - mill. $ -19.745 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.003 mill.
$ - mill.


$ -19.745 mill.
Employees Shares Outstanding P/E

-
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y 3,557.89 %


ALPP

$0.015

$-0.3580 -95.98%
This Quarter Q4 of 2024


ALPP

$0.015

$-0.3580 -95.98%



Alpine 4 Holdings Inc

Alpine 4 Holdings Inc shares went down -95.98% during this current quarter q4 of 2024.


Alpine 4 Holdings Inc operates as a holding company with a diversified business model, focusing on acquiring businesses that complement its existing portfolio and have the potential for growth. The company primarily aims to generate long-term value for its shareholders through strategic acquisitions, operational improvements, and fostering synergy among its subsidiaries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.411 mill. $ 103.725 mill. $ -56.752 mill. 27 mill. - Y/Y -7.72 %
Market Cap. Revenues TTM Net Income TTM

$ 0.411 mill.
$ 103.725 mill.


$ -56.752 mill.
Employees Shares Outstanding P/E

132
27 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -7.72 %
MRQ Y/Y - %


AMMJ

$0.0002

$-0.0046 -95.83%
This Quarter Q4 of 2024


AMMJ

$0.0002

$-0.0046 -95.83%



American Cannabis Company Inc

American Cannabis Company Inc stock went down -95.83% during this current quarter q4 of 2024.


American Cannabis Company Inc is a cannabis consulting and solutions provider operating in the United States. They offer a range of services including cultivation facility design, equipment sourcing, branding, and operational support to help businesses in the cannabis industry succeed. Their business model revolves around providing expertise and resources to clients in order to help them navigate the complexities of the cannabis market and maximize their profitability.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.017 mill. $ 2.020 mill. $ -0.133 mill. 86 mill. 0.23 Y/Y -64.10 %
Market Cap. Revenues TTM Net Income TTM

$ 0.017 mill.
$ 2.020 mill.


$ -0.133 mill.
Employees Shares Outstanding P/E

-
86 mill.
0.23
Revenue Growth Income Growth

MRQ Y/Y -64.10 %
MRQ Y/Y - %


GSIW

$0.538

$-7.6020 -93.39%
This Quarter Q4 of 2024


GSIW

$0.538

$-7.6020 -93.39%



Garden Stage Limited

Garden Stage Limited shares went down -93.39% during this current quarter q4 of 2024.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.323 mill. $ 1.982 mill. $ -4.589 mill. 14 mill. 1.58 Y/Y 0.00 %
Market Cap. Revenues TTM Net Income TTM

$ 7.323 mill.
$ 1.982 mill.


$ -4.589 mill.
Employees Shares Outstanding P/E

-
14 mill.
1.58
Revenue Growth Income Growth

MRQ Y/Y 0.00 %
MRQ Y/Y - %


TRNR

$2.89

$-40.1100 -93.28%
This Quarter Q4 of 2024


TRNR

$2.89

$-40.1100 -93.28%



Interactive Strength Inc

Interactive Strength Inc shares declined -93.28% during this current quarter q4 of 2024.


Interactive Strength Inc is a company that operates on a business model that focuses on providing interactive and engaging experiences for their clients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13.448 mill. $ 3.304 mill. $ -39.580 mill. 5 mill. - Y/Y 537.34 %
Market Cap. Revenues TTM Net Income TTM

$ 13.448 mill.
$ 3.304 mill.


$ -39.580 mill.
Employees Shares Outstanding P/E

-
5 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 537.34 %
MRQ Y/Y - %


SING

$0.029

$-0.3759 -92.84%
This Quarter Q4 of 2024


SING

$0.029

$-0.3759 -92.84%



Singlepoint Inc

Singlepoint Inc shares declined -92.84% during this current quarter q4 of 2024.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.000 mill. $ 35.904 mill. $ -30.434 mill. 0 mill. 0.00 Y/Y 1,624.03 %
Market Cap. Revenues TTM Net Income TTM

$ 0.000 mill.
$ 35.904 mill.


$ -30.434 mill.
Employees Shares Outstanding P/E

-
0 mill.
0.00
Revenue Growth Income Growth

MRQ Y/Y 1,624.03 %
MRQ Y/Y - %


IDEX

$0.0202

$-0.2398 -92.23%
This Quarter Q4 of 2024


IDEX

$0.0202

$-0.2398 -92.23%



Ideanomics inc

Ideanomics Inc shares declined -92.23% during this current quarter q4 of 2024.


Ideanomics Inc is a company that focuses on the development and implementation of technology solutions for sustainable transport and energy systems. Their business model involves partnering with various companies to provide innovative and efficient solutions for electric vehicles, charging infrastructure, and renewable energy sources.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.192 mill. $ 19.856 mill. $ -316.868 mill. 10 mill. - Y/Y -93.52 %
Market Cap. Revenues TTM Net Income TTM

$ 0.192 mill.
$ 19.856 mill.


$ -316.868 mill.
Employees Shares Outstanding P/E

295
10 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -93.52 %
MRQ Y/Y - %


TCBP

$0.6486

$-6.8514 -91.35%
This Quarter Q4 of 2024


TCBP

$0.6486

$-6.8514 -91.35%



Tc Biopharm holdings Plc

Tc Biopharm Holdings Plc shares declined -91.35% during this current quarter q4 of 2024.


Tc Biopharm Holdings Plc*s business model revolves around the development and commercialization of innovative cell therapies for the treatment of various diseases and medical conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.955 mill. $ - mill. $ -10.619 mill. 3 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.955 mill.
$ - mill.


$ -10.619 mill.
Employees Shares Outstanding P/E

-
3 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


GCTK

$0.255

$-2.3950 -90.38%
This Quarter Q4 of 2024


GCTK

$0.255

$-2.3950 -90.38%



Glucotrack Inc

Glucotrack Inc stock declined -90.38% during this current quarter q4 of 2024.


Glucotrack Inc*s business model is focused on developing and marketing innovative non-invasive glucose monitoring devices for individuals with diabetes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.396 mill. $ - mill. $ 12.051 mill. 5 mill. 0.40 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.396 mill.
$ - mill.


$ 12.051 mill.
Employees Shares Outstanding P/E

-
5 mill.
0.40
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y 281.72 %


NAVB

$0.0001

$-0.0009 -90.00%
This Quarter Q4 of 2024


NAVB

$0.0001

$-0.0009 -90.00%



Navidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Inc stock went down -90.00% during this current quarter q4 of 2024.


Navidea Biopharmaceuticals Inc*s business model revolves around the development and commercialization of innovative precision medicines and diagnostic tests. They focus on targeting specific diseases to provide more accurate diagnostics and targeted therapies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.010 mill. $ - mill. $ -1.182 mill. 99 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.010 mill.
$ - mill.


$ -1.182 mill.
Employees Shares Outstanding P/E

-
99 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


VAXX

$0.0001

$-0.0009 -90.00%
This Quarter Q4 of 2024


VAXX

$0.0001

$-0.0009 -90.00%



Vaxxinity Inc

Vaxxinity Inc shares went down -90.00% during this current quarter q4 of 2024.


Vaxxinity Inc is a company that operates on a business model that focuses on the development and distribution of vaccines.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.013 mill. $ - mill. $ -56.934 mill. 127 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.013 mill.
$ - mill.


$ -56.934 mill.
Employees Shares Outstanding P/E

-
127 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


LRCX

$76.59

$-679.3300 -89.87%
This Quarter Q4 of 2024


LRCX

$76.59

$-679.3300 -89.87%



Lam Research Corporation

Lam Research Corporation shares went down -89.87% during this current quarter q4 of 2024.


Lam Research Corporation operates as a global supplier of wafer fabrication equipment and services to the semiconductor industry, providing advanced solutions for the manufacturing of high-performance integrated circuits. The company primarily generates revenue through the sale, service, and support of its equipment, along with long-term contracts with semiconductor manufacturers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 99,878.415 mill. $ 15,590.772 mill. $ 4,056.818 mill. 1,304 mill. 24.73 Y/Y 19.70 %
Market Cap. Revenues TTM Net Income TTM

$ 99,878.415 mill.
$ 15,590.772 mill.


$ 4,056.818 mill.
Employees Shares Outstanding P/E

17,450
1,304 mill.
24.73
Revenue Growth Income Growth

MRQ Y/Y 19.70 %
MRQ Y/Y 25.81 %


LDSN

$0.0055

$-0.0473 -89.58%
This Quarter Q4 of 2024


LDSN

$0.0055

$-0.0473 -89.58%



Luduson G Inc

Luduson G Inc shares declined -89.58% during this current quarter q4 of 2024.


Luduson G Inc?s business model focuses on developing and selling innovative gaming software and applications to the digital gaming industry. The company emphasizes creating engaging and interactive gaming experiences for consumers while generating revenue through software licensing and sales.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ - mill. $ - mill. $ 12.214 mill. - mill. 0.28 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ - mill.
$ - mill.


$ 12.214 mill.
Employees Shares Outstanding P/E

-
- mill.
0.28
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


MINM

$0.35

$-2.9850 -89.51%
This Quarter Q4 of 2024


MINM

$0.35

$-2.9850 -89.51%



Minim Inc

Minim Inc stock went down -89.51% during this current quarter q4 of 2024.


Minim Inc is a technology company that provides innovative solutions for home Wi-Fi and network security. Their business model centers around developing and marketing hardware and software products that optimize and protect home networks. By offering a range of products and subscription services, they aim to cater to both individual consumers and service providers in the telecommunications industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.003 mill. $ - mill. $ -5.517 mill. 3 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.003 mill.
$ - mill.


$ -5.517 mill.
Employees Shares Outstanding P/E

-
3 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


VMAR

$1.72

$-14.5700 -89.44%
This Quarter Q4 of 2024


VMAR

$1.72

$-14.5700 -89.44%



Vision Marine Technologies inc

Vision Marine Technologies Inc stock went down -89.44% during this current quarter q4 of 2024.


Vision Marine Technologies Inc. operates as an electric powerboat manufacturer, specializing in the development and production of environmentally friendly, zero-emission electric boats.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.063 mill. $ 4.329 mill. $ -15.992 mill. 1 mill. - Y/Y -23.12 %
Market Cap. Revenues TTM Net Income TTM

$ 1.063 mill.
$ 4.329 mill.


$ -15.992 mill.
Employees Shares Outstanding P/E

-
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -23.12 %
MRQ Y/Y - %


SAVA

$3.22

$-26.2300 -89.07%
This Quarter Q4 of 2024


SAVA

$3.22

$-26.2300 -89.07%



Cassava Sciences Inc

Cassava Sciences Inc stock went down -89.07% during this current quarter q4 of 2024.


Cassava Sciences Inc is a pharmaceutical company that focuses on developing and commercializing novel drugs for neurological diseases. Their business model revolves around researching and developing innovative therapeutic solutions, conducting clinical trials to assess the effectiveness of their drugs, and ultimately marketing and selling their approved products to healthcare providers and patients. By strategically investing in the development of drugs for neurological disorders, Cassava Sciences aims to address unmet medical needs and potentially generate revenue through drug sales.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 154.483 mill. $ - mill. $ 26.128 mill. 48 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 154.483 mill.
$ - mill.


$ 26.128 mill.
Employees Shares Outstanding P/E

24
48 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


WINT

$0.37

$-2.7000 -87.95%
This Quarter Q4 of 2024


WINT

$0.37

$-2.7000 -87.95%



Windtree Therapeutics Inc

Windtree Therapeutics Inc stock declined -87.95% during this current quarter q4 of 2024.


Windtree Therapeutics Inc is a biotechnology company that develops novel gene therapies to treat respiratory diseases by delivering therapeutic proteins to the lungs. They aim to address unmet medical needs and improve the lives of patients through their innovative treatment approaches.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.328 mill. $ - mill. $ -9.136 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.328 mill.
$ - mill.


$ -9.136 mill.
Employees Shares Outstanding P/E

19
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


DBGI

$0.1025

$-0.7475 -87.94%
This Quarter Q4 of 2024


DBGI

$0.1025

$-0.7475 -87.94%



Digital Brands Group Inc

Digital Brands Group Inc stock declined -87.94% during this current quarter q4 of 2024.


Digital Brands Group Inc. operates as a digitally native vertical brand company. It partners with designers, manufacturers, and influencers to create and sell direct-to-consumer luxury apparel and accessories through its online platform. By cutting out the middleman, the company aims to offer high-quality, designer products at affordable prices to consumers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.173 mill. $ 10.392 mill. $ -13.349 mill. 2 mill. - Y/Y -40.99 %
Market Cap. Revenues TTM Net Income TTM

$ 0.173 mill.
$ 10.392 mill.


$ -13.349 mill.
Employees Shares Outstanding P/E

-
2 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -40.99 %
MRQ Y/Y - %


OMEX

$0.4899

$-3.5701 -87.93%
This Quarter Q4 of 2024


OMEX

$0.4899

$-3.5701 -87.93%



Odyssey Marine Exploration Inc

Odyssey Marine Exploration Inc shares dropped -87.93% during this current quarter q4 of 2024.


Odyssey Marine Exploration Inc is a company that specializes in the discovery and recovery of deep-sea shipwrecks and their precious cargoes. Their business model revolves around using advanced technology and expertise to locate and excavate historically significant shipwrecks for the purpose of selling recovered artifacts and potentially valuable items. They generate revenue through the sale of these artifacts, as well as through licensing agreements and partnerships with museums, governments, and other organizations.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 12.355 mill. $ 0.633 mill. $ 34.100 mill. 25 mill. 0.52 Y/Y 23.95 %
Market Cap. Revenues TTM Net Income TTM

$ 12.355 mill.
$ 0.633 mill.


$ 34.100 mill.
Employees Shares Outstanding P/E

38
25 mill.
0.52
Revenue Growth Income Growth

MRQ Y/Y 23.95 %
MRQ Y/Y - %


JTAI

$4

$-25.2500 -86.32%
This Quarter Q4 of 2024


JTAI

$4

$-25.2500 -86.32%



Jet ai Inc

Jet Ai Inc stock dropped -86.32% during this current quarter q4 of 2024.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 51.625 mill. $ 17.280 mill. $ -20.078 mill. 13 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 51.625 mill.
$ 17.280 mill.


$ -20.078 mill.
Employees Shares Outstanding P/E

-
13 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


PBM

$2.37

$-14.8800 -86.26%
This Quarter Q4 of 2024


PBM

$2.37

$-14.8800 -86.26%



Psyence Biomedical ltd

Psyence Biomedical Ltd shares went down -86.26% during this current quarter q4 of 2024.


Pacific Booker Minerals Inc is engaged in the exploration and development of mineral properties, primarily focused on copper and gold projects in British Columbia, Canada. The company acquires mining rights and conducts extensive exploration to identify mineral deposits. Once a viable deposit is discovered, Pacific Booker Minerals Inc aims to develop and operate a mining operation to extract the minerals and sell them in the market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 15.446 mill. $ 0.001 mill. $ -51.159 mill. 7 mill. - Y/Y -20.00 %
Market Cap. Revenues TTM Net Income TTM

$ 15.446 mill.
$ 0.001 mill.


$ -51.159 mill.
Employees Shares Outstanding P/E

-
7 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -20.00 %
MRQ Y/Y - %


TBIO

$0.57

$-3.5000 -86.00%
This Quarter Q4 of 2024


TBIO

$0.57

$-3.5000 -86.00%



Telesis Bio Inc

Telesis Bio Inc stock declined -86.00% during this current quarter q4 of 2024.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.010 mill. $ 13.962 mill. $ -45.551 mill. 2 mill. - Y/Y -68.66 %
Market Cap. Revenues TTM Net Income TTM

$ 1.010 mill.
$ 13.962 mill.


$ -45.551 mill.
Employees Shares Outstanding P/E

11
2 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -68.66 %
MRQ Y/Y - %


TFFP

$0.2898

$-1.6702 -85.21%
This Quarter Q4 of 2024


TFFP

$0.2898

$-1.6702 -85.21%



Tff Pharmaceuticals Inc

Tff Pharmaceuticals Inc stock dropped -85.21% during this current quarter q4 of 2024.


TFF Pharmaceuticals Inc*s business model revolves around developing and commercializing novel drug therapies using its Thin Film Freezing (TFF) technology, which enhances the solubility and stability of drugs for improved delivery and patient outcomes. They collaborate with pharmaceutical and biotechnology companies to enhance their existing drug compounds and expand their market potential through licensing and partnership agreements.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.267 mill. $ 1.282 mill. $ -18.169 mill. 4 mill. - Y/Y -41.99 %
Market Cap. Revenues TTM Net Income TTM

$ 1.267 mill.
$ 1.282 mill.


$ -18.169 mill.
Employees Shares Outstanding P/E

11
4 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -41.99 %
MRQ Y/Y - %


CMCT

$0.2867

$-1.6133 -84.91%
This Quarter Q4 of 2024


CMCT

$0.2867

$-1.6133 -84.91%



Creative Media and Community Trust Corporation

Creative Media And Community Trust Corporation shares dropped -84.91% during this current quarter q4 of 2024.


Creative Media and Community Trust Corporation is a multimedia organization that operates on a unique business model. They focus on creating and distributing innovative media content that promotes community engagement and trust. This involves collaborating with local communities, organizations, and individuals to develop compelling stories and platforms that empower and connect people.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 8.169 mill. $ 126.521 mill. $ -24.205 mill. 28 mill. - Y/Y 1.77 %
Market Cap. Revenues TTM Net Income TTM

$ 8.169 mill.
$ 126.521 mill.


$ -24.205 mill.
Employees Shares Outstanding P/E

-
28 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 1.77 %
MRQ Y/Y - %


NVOS

$0.044

$-0.2460 -84.83%
This Quarter Q4 of 2024


NVOS

$0.044

$-0.2460 -84.83%



Novo Integrated Sciences Inc

Novo Integrated Sciences Inc shares declined -84.83% during this current quarter q4 of 2024.


Novo Integrated Sciences Inc is a company that operates as a healthcare organization providing medical services and products. Their business model focuses on leveraging technology and innovation to deliver personalized and comprehensive healthcare solutions to patients and medical professionals. Novo Integrated Sciences Inc aims to optimize patient outcomes and healthcare efficiency through the integration of various medical disciplines and data-driven approaches.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.776 mill. $ 7.660 mill. $ 16.306 mill. 18 mill. 0.02 Y/Y 17.92 %
Market Cap. Revenues TTM Net Income TTM

$ 0.776 mill.
$ 7.660 mill.


$ 16.306 mill.
Employees Shares Outstanding P/E

-
18 mill.
0.02
Revenue Growth Income Growth

MRQ Y/Y 17.92 %
MRQ Y/Y - %


SYRS

$0.2342

$-1.2958 -84.69%
This Quarter Q4 of 2024


SYRS

$0.2342

$-1.2958 -84.69%



Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc shares dropped -84.69% during this current quarter q4 of 2024.


Syros Pharmaceuticals Inc operates based on a business model focused on developing targeted gene control therapies to treat various diseases. The company aims to leverage its gene control platform to identify and exploit unique gene regulatory networks to discover and develop novel therapeutics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9.212 mill. $ - mill. $ -97.815 mill. 39 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 9.212 mill.
$ - mill.


$ -97.815 mill.
Employees Shares Outstanding P/E

-
39 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


EFSH

$0.331

$-1.8290 -84.68%
This Quarter Q4 of 2024


EFSH

$0.331

$-1.8290 -84.68%



1847 Holdings Llc

1847 Holdings Llc shares went down -84.68% during this current quarter q4 of 2024.


1847 Holdings LLC operates as a holding company with a diversified business model. It acquires, manages, and grows subsidiary companies across various industries, aiming to create value and maximize returns for its shareholders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.409 mill. $ 53.952 mill. $ -18.809 mill. 13 mill. - Y/Y -75.46 %
Market Cap. Revenues TTM Net Income TTM

$ 4.409 mill.
$ 53.952 mill.


$ -18.809 mill.
Employees Shares Outstanding P/E

45
13 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -75.46 %
MRQ Y/Y - %


CRKN

$0.2491

$-1.3609 -84.53%
This Quarter Q4 of 2024


CRKN

$0.2491

$-1.3609 -84.53%



Crown Electrokinetics Corp

Crown Electrokinetics Corp stock went down -84.53% during this current quarter q4 of 2024.


Crown Electrokinetics Corp*s business model is focused on the development and commercialization of innovative electrokinetic display technologies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.433 mill. $ 5.367 mill. $ -32.891 mill. 2 mill. - Y/Y 21,027.27 %
Market Cap. Revenues TTM Net Income TTM

$ 0.433 mill.
$ 5.367 mill.


$ -32.891 mill.
Employees Shares Outstanding P/E

11
2 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 21,027.27 %
MRQ Y/Y - %


MTNB

$0.579

$-3.0610 -84.09%
This Quarter Q4 of 2024


MTNB

$0.579

$-3.0610 -84.09%



Matinas Biopharma Holdings Inc

Matinas Biopharma Holdings Inc shares dropped -84.09% during this current quarter q4 of 2024.


Matinas Biopharma Holdings Inc operates as a clinical-stage biopharmaceutical company. Their business model centers around developing therapeutics through the utilization of lipid nano-crystal (LNC) platform technologies. These technologies enable the effective delivery of drugs to improve patient outcomes in various diseases and conditions such as fungal infections, viral infections, and cancer.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.887 mill. $ - mill. $ -7.664 mill. 5 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 2.887 mill.
$ - mill.


$ -7.664 mill.
Employees Shares Outstanding P/E

202
5 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


EDBL

$0.1691

$-0.8709 -83.74%
This Quarter Q4 of 2024


EDBL

$0.1691

$-0.8709 -83.74%



Edible Garden Ag Incorporated

Edible Garden Ag Incorporated stock declined -83.74% during this current quarter q4 of 2024.


Edible Garden Ag Incorporated*s business model revolves around cultivating and providing edible plants and produce to consumers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.534 mill. $ 14.068 mill. $ -14.275 mill. 3 mill. - Y/Y -21.44 %
Market Cap. Revenues TTM Net Income TTM

$ 0.534 mill.
$ 14.068 mill.


$ -14.275 mill.
Employees Shares Outstanding P/E

-
3 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -21.44 %
MRQ Y/Y - %


TTOO

$0.51

$-2.5800 -83.50%
This Quarter Q4 of 2024


TTOO

$0.51

$-2.5800 -83.50%



T2 Biosystems Inc

T2 Biosystems Inc stock went down -83.50% during this current quarter q4 of 2024.


T2 Biosystems Inc operates on a business model centered around developing and commercializing innovative diagnostic solutions for medical purposes. Their technology relies on magnetic resonance for the detection of pathogens, toxins, and other molecules associated with various diseases. By offering rapid, accurate, and portable diagnostic capabilities, T2 Biosystems aims to improve patient outcomes and facilitate appropriate treatment decisions in healthcare settings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9.125 mill. $ 7.470 mill. $ -48.039 mill. 18 mill. - Y/Y 1.07 %
Market Cap. Revenues TTM Net Income TTM

$ 9.125 mill.
$ 7.470 mill.


$ -48.039 mill.
Employees Shares Outstanding P/E

-
18 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 1.07 %
MRQ Y/Y - %


SPEC

$0.016

$-0.0784 -83.05%
This Quarter Q4 of 2024


SPEC

$0.016

$-0.0784 -83.05%



Perception Capital Corp Ii

Perception Capital Corp Ii shares went down -83.05% during this current quarter q4 of 2024.


Spectaire Holdings Inc*s business model focuses on an undisclosed approach and cannot be described without further information.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.033 mill. $ - mill. $ -28.258 mill. 2 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.033 mill.
$ - mill.


$ -28.258 mill.
Employees Shares Outstanding P/E

-
2 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


EYEN

$0.0877

$-0.4251 -82.90%
This Quarter Q4 of 2024


EYEN

$0.0877

$-0.4251 -82.90%



Eyenovia inc

Eyenovia Inc stock dropped -82.90% during this current quarter q4 of 2024.


Eyenovia Inc*s business model revolves around developing and commercializing innovative ophthalmic products utilizing its proprietary microfluidic ejection technology. The company aims to enhance treatment options for eye diseases and conditions by delivering more precise and targeted ocular therapeutics. Eyenovia focuses on creating user-friendly, high-precision, and cost-effective eye droppers to improve patient compliance and overall treatment outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.100 mill. $ 0.032 mill. $ -37.831 mill. 70 mill. - Y/Y 35.64 %
Market Cap. Revenues TTM Net Income TTM

$ 6.100 mill.
$ 0.032 mill.


$ -37.831 mill.
Employees Shares Outstanding P/E

10
70 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 35.64 %
MRQ Y/Y - %



 1 Day   Week  Current Month of December  30 Days 
Current Quarter Q4 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com